Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006166 · ClinicalTrials.gov registry record · Phase 3
North American Study for the Treatment of Refractory Ascites (NASTRA)
A Phase 3 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00006166: Completed Phase 3 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00006166 is a Phase 3 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006166, a Phase 3 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The NASTRA Clinical Trial is a multi-center, randomized, controlled clinical trial designed to determine if treatment with transjugular intrahepatic portasystemic shunts (TIPS) is superior to high volume paracentesis (total paracentesis, TP) for the treatment of refractory ascites due to cirrhosis. Only patients with clinically tense symptomatic ascites (shortness of breath, umbilical hernia, abdominal pain and/or distension, and/or limitation of activity) who have either diuretic-resistant ascites or diuretic-intractable ascites are being studied.
Interventions
- PROCEDURE Transjugular intrahepatic portasystemic shunts (TIPS)
- PROCEDURE Total paracentecis (TP)
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-03 |
| Est. Completion | 2001-10 |
| Phase | Phase 3 |
What the finished NCT00006166 record still lists
NCT00006166 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Transjugular intrahepatic portasystemic shunts (TIPS) is the first listed.
NCT00006166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006166 about?
NCT00006166 is a clinical study titled "North American Study for the Treatment of Refractory Ascites (NASTRA)". The NASTRA Clinical Trial is a multi-center, randomized, controlled clinical trial designed to determine if treatment with transjugular intrahepatic portasystemic shunts (TIPS) is superior to high volume paracentesis (total paracentesis, TP) for the treatment of refractory ascites due to cirrhosis. ...
What is the current status of trial NCT00006166?
This trial is currently completed. It is a Phase 3 study. The study started on 1997-03. Estimated completion is 2001-10.
What interventions are being tested in trial NCT00006166?
The interventions under investigation include: Transjugular intrahepatic portasystemic shunts (TIPS) (PROCEDURE), Total paracentecis (TP) (PROCEDURE).
Who is sponsoring clinical trial NCT00006166?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia